Table 1 Clinical characteristics of patients and newborns in the validation cohort
From: Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus
|  | NGT (n = 14) | GDM (n = 8) | p values |
|---|---|---|---|
Maternal baseline characteristics | |||
 Age (years) | 31.6 ± 5.24 | 36.9 ± 3.02 | 0.003 |
 Race |  |  | 0.256 |
 Chinese | 1 (5.56%) | 0 |  |
 European | 8 (44.4%) | 8 (88.9%) |  |
 Indian–Pakistan | 3 (16.7%) | 0 |  |
 Latin–American | 5 (27.8%) | 1 (11.1%) |  |
 Philipina | 1 (5.56&) | 0 |  |
 Height (cms) | 162 ± 6.13 | 162 ± 3.52 | 0.929 |
 Pre-gestational weight (kg) | 66.6 ± 13.9 | 61.7 ± 13.7 | 0.398 |
 Pre-gestational BMI | 25.3 ± 4.67 | 23.5 ± 5.46 | 0.411 |
Screening and diagnostic results | |||
 Gestational age O´Sullivan test | 23.6 ± 3.6 | 24.4 ± 1.25 | 0.52 |
 O’Sullivan test result (mmol/L) | 7.0 ± 1.67 | 9.70 ± 1.88 | 0.004 |
 Gestational age at OGTT | 26.4 ± 0.55 | 26.0 ± 0.75 | 0.266 |
 Fasting OGTT (mmol/L) | 4.38 ± 0.25 | 4.58 ± 0.53 | 0.342 |
 1 h OGTT (mmol/L) | 8.22 ± 1.16 | 11.1 ± 1.15 |  < 0.001 |
 2 h OGTT (mmol/L) | 6.64 ± 2.14 | 10.0 ± 1.45 | 0.005 |
 3 h OGTT (mmol/L) | 5.21 ± 2.01 | 7.79 ± 1.50 | 0.016 |
Delivery data | |||
 Gestational age at delivery (weeks) | 39.6 ± 1.2 | 39.1 (± 1.22) | 0.298 |
 Fetal sex (male/female) | 11/7 | 3/6 | 0.236 |
 Birthweight (grams) | 3480 ± 148 | 3154 ± 100 | 0.208 |
 Birthweight percentile | 47.8 ± 31.4 | 43.2 (± 25.1) | 0.684 |
Route of delivery | 0.363 | ||
 Cesarean | 6 (33.3%) | 1 (11.1%) |  |
 Vaginal | 12 (66.7%) | 8 (88.9%) |  |